Searched for
PATENT DISPUTES
Nokia wins UK appeal to block Acer, Asus video streaming patent lawsuitsNokia has successfully blocked lawsuits filed by Acer and Asus in London. The dispute centers on video coding technology. Nokia's appeal me...
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
Battle of paradigm shifters: Musk vs Altman over OpenAI's original purpose can shape AI's moral & commercial futureMusk’s lawsuit against Sam Altman and OpenAI, along with Microsoft, has turned into a broader debate over who controls the future of artifi...
US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
After tariff wars, Trump is opening a new front in US-China rivalryThe US accuses China of stealing AI intellectual property, escalating the tech rivalry beyond tariffs. This move, potentially impacting chi...
SBI moves Supreme Court seeking review of spectrum ruling, flags impact on telecom insolvenciesThe State Bank of India is asking the Supreme Court to reconsider a recent ruling. The judgment prevents telecom spectrum from being treate...
Apple defeats bid for new Apple Watch import ban at US trade tribunalA US trade tribunal ruled for Apple on Friday against a bid from medtech company Masimo to reinstate an import ban on the tech giant's Appl...
Why Apple stock is down today: Foldable iPhone delay, China patent battle and AAPL stock price prediction explainedAAPL stock today: Apple shares dipped despite strong earnings, as investors fret over future innovation. Delays in the much-anticipated fol...
Non-violation complaints under WTO's TRIPS agreement: An explainerWorld Trade Organisation members could not agree to extend a safeguard on intellectual property rules. This means the moratorium on non-vio...
Apple to pause selling new versions of its watch after losing patent disputeTwo months ago, Apple lost a patent case over the technology its smartwatches use to detect people's pulse rate. The company was ordered to...
Apple to halt US sales of Series 9, Ultra 2 smartwatches on patent disputeApple said on Monday it would pause sales of its Series 9 and Ultra 2 smartwatches in the United States from this week, as it deals with a ...
Nokia, Lenovo settle patent dispute over video-compression technologyNokia had launched its legal battle against Lenovo in 2019 over alleged infringement of 20 video-compression technology patents and had cas...
- Teva settles patent dispute with Orchid Pharma
Teva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...
- Ranbaxy settles patent dispute with Roche
Daiichi Sankyo-owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for the latter’s drug valganciclovir sold u...
- Samsung settles patent dispute with Kodak
Eastman Kodak says Samsung Electronics has agreed to pay the photography company an undisclosed sum to settle a patent dispute over digital...
- Patent disputes give global biggies the jitters
The US Supreme Court on Monday considers a patent dispute that will determine how much legal protection is afforded abstract business innov...
- Zydus, Teva end patent disputes
Ahmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...
- Teva, Glenmark call an end to patent dispute
Israeli generic major Teva and Mumbai-based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Coreg -...
- Ranbaxy and Pfizer settle Lipitor patent disputes
Ranbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...